These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34859378)

  • 21. Leaflet immobility and thrombosis in transcatheter aortic valve replacement.
    Ng ACT; Holmes DR; Mack MJ; Delgado V; Makkar R; Blanke P; Leipsic JA; Leon MB; Bax JJ
    Eur Heart J; 2020 Sep; 41(33):3184-3197. PubMed ID: 32930773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoattenuated Leaflet Thickening After Implantation of the ACURATE neo or the ACURATE neo2 Transcatheter Heart Valve.
    Brunner S; Brinkert M; Moccetti F; Loretz L; Fornaro J; Stämpfli SF; Attinger-Toller A; Bossard M; Buhmann R; Cuculi F; Wolfrum M; Toggweiler S
    Am J Cardiol; 2023 Aug; 200():146-152. PubMed ID: 37321028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-Vitro Assessment of the Effects of Transcatheter Aortic Valve Leaflet Design on Neo-Sinus Geometry and Flow.
    Ncho B; Sadri V; Ortner J; Kollapaneni S; Yoganathan A
    Ann Biomed Eng; 2021 Mar; 49(3):1046-1057. PubMed ID: 33098058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood Stasis on Transcatheter Valve Leaflets and Implications for Valve-in-Valve Leaflet Thrombosis.
    Vahidkhah K; Javani S; Abbasi M; Azadani PN; Tandar A; Dvir D; Azadani AN
    Ann Thorac Surg; 2017 Sep; 104(3):751-759. PubMed ID: 28483152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Vollema EM; Kong WKF; Katsanos S; Kamperidis V; van Rosendael PJ; van der Kley F; de Weger A; Ajmone Marsan N; Delgado V; Bax JJ
    Eur Heart J; 2017 Apr; 38(16):1207-1217. PubMed ID: 28369242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
    Moscarelli M; Sollami G; Lentini E; Prestera R; Pernice V; Milo S; Violante F; Cuffari F; Di Pasquale C; Ferlisi A; La Grutta L; Grassedonio E; Speziale G; Fattouch K
    Int J Cardiol; 2024 Mar; 398():131597. PubMed ID: 37979790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sinus Hemodynamics Variation with Tilted Transcatheter Aortic Valve Deployments.
    Hatoum H; Dollery J; Lilly SM; Crestanello JA; Dasi LP
    Ann Biomed Eng; 2019 Jan; 47(1):75-84. PubMed ID: 30151733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioprosthesis leaflet thrombosis following self-expanding valve-in-valve transcatheter aortic valve replacement in patient taking factor Xa inhibitor and warfarin: A case report.
    Buchanan KD; Alraies MC; Weissman G; Ben-Dor I; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):29-32. PubMed ID: 29066342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement.
    Rashid HN; Michail M; Ramnarain J; Nasis A; Nicholls SJ; Cameron JD; Gooley RP
    J Cardiovasc Comput Tomogr; 2022; 16(2):168-173. PubMed ID: 34852974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation and Subclinical Valve Thrombosis After TAVR.
    Dangas G; Nicolas J
    JACC Cardiovasc Interv; 2022 Sep; 15(18):1805-1807. PubMed ID: 36057537
    [No Abstract]   [Full Text] [Related]  

  • 31. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
    Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
    Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation Therapy After Transcatheter Aortic Valve Replacement.
    Chakravarty T; Jilaihawi H; de la Rosa A; Makkar R
    Curr Cardiol Rep; 2020 Oct; 22(12):175. PubMed ID: 33040213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Patient-Specific Characteristics on Transcatheter Heart Valve Neo-Sinus Flow: An In Silico Study.
    Singh-Gryzbon S; Ncho B; Sadri V; Bhat SS; Kollapaneni SS; Balakumar D; Wei ZA; Ruile P; Neumann FJ; Blanke P; Yoganathan AP
    Ann Biomed Eng; 2020 Oct; 48(10):2400-2411. PubMed ID: 32415483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender Differences and Outcomes of Hypoattenuated Leaflet Thickening (HALT) Following Transcatheter Aortic Valve Replacement: A Meta-analysis of Randomized and Cohort Studies.
    Salah HM; Almaddah N; Xu J; Al-Hawwas M; Agarwal SK; Uretsky BF; Dhar G; Al'Aref SJ
    Curr Probl Cardiol; 2023 Jul; 48(7):101155. PubMed ID: 35192871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational fluid dynamics simulation of transcatheter aortic valve degeneration.
    Dwyer HA; Matthews PB; Azadani A; Jaussaud N; Ge L; Guy TS; Tseng EE
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):301-8. PubMed ID: 19414489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes.
    Waksman R; Bhogal S; Gordon P; Ehsan A; Wilson SR; Levitt R; Parikh P; Bilfinger T; Hanna N; Buchbinder M; Asch FM; Kim FY; Weissman G; Ben-Dor I; Shults CC; Ali S; Sutton JA; Shea C; Zhang C; Garcia-Garcia HM; Satler LF; Rogers T
    Circ Cardiovasc Interv; 2023 May; 16(5):e012655. PubMed ID: 37192308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Roule V; Guedeney P; Silvain J; Beygui F; Zeitouni M; Sorrentino S; Kerneis M; Barthelemy O; Beaupré F; Portal JJ; Vicaut E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2023 Dec; 116(12):563-571. PubMed ID: 37968182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical valve leaflet thrombosis following bioprosthetic aortic valve replacement.
    Giuliani C; Zanuttini A; Salaun E; Côté N; Clavel MA; Pibarot P
    Curr Opin Cardiol; 2024 Sep; 39(5):457-464. PubMed ID: 38899782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Bioprosthetic Valve Dysfunction Following TAVR: The Role of CT Imaging in Diagnosing Acute Leaflet Thrombosis.
    Rashid HN; Cameron JD; Gooley RP
    Heart Lung Circ; 2022 Aug; 31(8):e120-e122. PubMed ID: 35513965
    [No Abstract]   [Full Text] [Related]  

  • 40. Neosinus Flow Stasis Correlates With Thrombus Volume Post-TAVR: A Patient-Specific In Vitro Study.
    Trusty PM; Sadri V; Madukauwa-David ID; Funnell E; Kamioka N; Sharma R; Makkar R; Babaliaros V; Yoganathan AP
    JACC Cardiovasc Interv; 2019 Jul; 12(13):1288-1290. PubMed ID: 31272673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.